Skip to main content
Clinical Trials/NCT04322994
NCT04322994CompletedNot Applicable

Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Use in Pediatric Populations: A Randomized Prospective Multi-Site Trial

Stanford University10 sites in 1 country175 target enrollmentStarted: October 21, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
175
Locations
10
Primary Endpoint
Number of Participants With 4% Decrease From Baseline in Oxygen Desaturation Index

Study Overview

Brief Summary

THRIVE (Transnasal Humidified Rapid-Insufflation Ventilatory Exchange) refers to the use of high-flow nasal cannula to augment the ability to oxygenate and ventilate a patient under general anesthesia. The use of high-flow nasal cannula oxygen supplementation during anesthesia for surgical procedures has been a recent development in the adult population, with limited data analyzing the pediatric population. This study will determine whether high flow nasal cannula oxygen supplementation during surgical or endoscopic procedures can prevent desaturation events in children under anesthesia and improve the outcomes of that surgery.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
— to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Pediatric patients less than 18 years of age undergoing general anesthesia for procedures or surgeries

Exclusion Criteria

  • Pregnancy
  • Absence of parent or legal guardian able to provide written consent for study participation
  • Anatomical or surgical contraindications (epistaxis, basilar skull fractures or abnormalities, nasal surgery or obstruction, nasal fractures, nasal vascular abnormalities), tracheostomy tube
  • Emergent surgery for which application of HFNC might delay surgery or might result in increased aspiration risk.

Outcomes

Primary Outcomes

Number of Participants With 4% Decrease From Baseline in Oxygen Desaturation Index

Time Frame: Duration of surgery or procedure, which is generally less than 2 hours

Oxygen desaturation index is defined as a 4% decrease in saturation from a 120 second rolling mean for greater than 10 seconds; data were recorded every 2 seconds while the procedure was being performed.

Number of Participants With Desaturations <90%

Time Frame: Duration of surgery or procedure, which is generally less than 2 hours

Relative incidence of oxygen desaturation less than 90% as measured by pulse oximetry by second adjusted for post surgical diagnosis; data were recorded every 2 seconds while the procedure was being performed.

Number of Participants Who Ever Either Fall Below 90% O2 or Drop 4% Below Baseline Saturation

Time Frame: Duration of surgery or procedure, which is generally less than 2 hours

Relative incidence of oxygen desaturation less than 90% as measured by pulse oximetry by second adjusted for post surgical diagnosis; data were recorded every 2 seconds while the procedure was being performed. Participants who experienced both a fall below 90% O2 and a 4% drop below baseline saturation are reported as having more than 1 event.

Secondary Outcomes

  • Number of Participants With Surgical Interruptions Due to Desaturation(Duration of surgery or procedure, which is generally less than 2 hours)
  • Time-normalized Area Under Curve (AUC) of Desaturations <90%(Duration of surgery or procedure, which is generally less than 2 hours)
  • Minimum Oxygen Saturation as a Measure of Desaturation Severity(Duration of surgery or procedure by second, which is generally less than 2 hours)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Thomas Caruso

Clinical Associate Professor

Stanford University

Study Sites (10)

Loading locations...

Similar Trials